Saturday, March 3, 2007
Article in the Wall Street Journal -- Merck Receives a Split Verdict From New Jersey Jury in Vioxx Trial, by Heather Won Tesoriero. Here's an excerpt:
A New Jersey state court jury delivered a split verdict in the first phase of the latest Vioxx trial, finding that Merck & Co. adequately warned doctors of the drug's heart-attack risks in the case of one plaintiff but not of another.
The eight-person jury found that in the case of both plaintiffs the drug maker violated a state consumer-protection statute by misrepresenting the drug's cardiovascular risks in marketing.
The Wall Street Journal also provides an updated trial scorecard for the Vioxx litigation.